↓ Skip to main content

Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran

Overview of attention for article published in Molecular Diagnosis & Therapy, December 2019
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
2 Dimensions
Title
Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran
Published in
Molecular Diagnosis & Therapy, December 2019
DOI 10.1007/s40291-019-00438-6
Pubmed ID
Authors

Pedro Renato de Paula Brandão, Simoneide S. Titze-de-Almeida, Ricardo Titze-de-Almeida

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2019.
All research outputs
#11,173,518
of 14,088,628 outputs
Outputs from Molecular Diagnosis & Therapy
#154
of 243 outputs
Outputs of similar age
#189,341
of 265,474 outputs
Outputs of similar age from Molecular Diagnosis & Therapy
#2
of 4 outputs
Altmetric has tracked 14,088,628 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 243 research outputs from this source. They receive a mean Attention Score of 2.6. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,474 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.